Biotechnology: Hype Surrounds Genomics Inc.

See allHide authors and affiliations

Science  07 Feb 1997:
Vol. 275, Issue 5301, pp. 770
DOI: 10.1126/science.275.5301.770

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Academics, researchers at older biotech and big pharmaceutical companies, and even some stock analysts worry that the promise of genomics is being oversold. As one prominent researcher puts it, “For a number of genetic diseases, knowing the genes might not help the patient one whit.”